Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Oct 2016. Module: Canada Health Infoway English module (core metadata concept)
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 138791000087113 | BAT [Botulism Antitoxin Heptavalent (A, B, C, D, E, F, G) - (Equine)] solution for injection Cangene Corporation (real clinical drug) | en | Fully specified name | Active | Entire term case sensitive (core metadata concept) | Canada Health Infoway English module (core metadata concept) |
| 72081000087119 | BAtx BAT Cang | en | Synonym (core metadata concept) | Active | Entire term case sensitive (core metadata concept) | Canada Health Infoway English module (core metadata concept) |
| 72101000087110 | BAT [Botulism Antitoxin Heptavalent (A, B, C, D, E, F, G) - (Equine)] solution for injection Cangene Corporation | en | Synonym (core metadata concept) | Active | Entire term case sensitive (core metadata concept) | Canada Health Infoway English module (core metadata concept) |
| 72991000087116 | AtxB BAT Cang | fr | Synonym (core metadata concept) | Active | Entire term case sensitive (core metadata concept) | Canada Health Infoway French module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| BAT [Botulism Antitoxin Heptavalent (A, B, C, D, E, F, G) - (Equine)] solution for injection Cangene Corporation (real clinical drug) | Count of base of active ingredient | un | false | Inferred relationship | Some | ||
| BAT [Botulism Antitoxin Heptavalent (A, B, C, D, E, F, G) - (Equine)] solution for injection Cangene Corporation (real clinical drug) | a une forme pharmaceutique (attribut) | solution pour injection (forme pharmaceutique) | true | Inferred relationship | Some | ||
| BAT [Botulism Antitoxin Heptavalent (A, B, C, D, E, F, G) - (Equine)] solution for injection Cangene Corporation (real clinical drug) | Has supplier | Cangene Corporation (supplier) | true | Inferred relationship | Some | ||
| BAT [Botulism Antitoxin Heptavalent (A, B, C, D, E, F, G) - (Equine)] solution for injection Cangene Corporation (real clinical drug) | est un(e) (attribut) | Product manufactured as parenteral dose form (product) | true | Inferred relationship | Some | ||
| BAT [Botulism Antitoxin Heptavalent (A, B, C, D, E, F, G) - (Equine)] solution for injection Cangene Corporation (real clinical drug) | Count of active ingredient | sept | false | Inferred relationship | Some | ||
| BAT [Botulism Antitoxin Heptavalent (A, B, C, D, E, F, G) - (Equine)] solution for injection Cangene Corporation (real clinical drug) | est un(e) (attribut) | Product containing only botulism antitoxin 7 serotypes (medicinal product) | true | Inferred relationship | Some | ||
| BAT [Botulism Antitoxin Heptavalent (A, B, C, D, E, F, G) - (Equine)] solution for injection Cangene Corporation (real clinical drug) | a pour principe actif (attribut) | Botulinum antitoxin (substance) | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
FHIR